Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45339 | 25117963 | J Acquir Immune Defic Syndr | Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects. | 2014 | Details |
| A45340 | 25117774 | Clin Gastroenterol Hepatol | Trials and tribulations in drug development for nonalcoholic steatohepatitis. | 2014 | Details |
| A45444 | 24516926 | Zhonghua Gan Zang Bing Za Zhi | [Current status of gut microbiota and metagenome with nonalcoholic fatty liver disease]. | 2013 | Details |
| A45451 | 24492426 | Transplantation | Sequential split liver followed by isolated intestinal transplant: the "liver-first" approach: report of a case. | 2014 | Details |
| A45499 | 24286951 | Endocrinol Metab Clin North Am | Gastrointestinal complications of diabetes. | 2013 | Details |
| A45508 | 24217034 | Ann Nutr Metab | Clinical consequences of diet-induced dysbiosis. | 2013 | Details |
| A45513 | 24202306 | Arterioscler Thromb Vasc Biol | Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice. | 2013 | Details |
| A45524 | 24143116 | Diabetes Metab Syndr Obes | Hepatic function and the cardiometabolic syndrome. | 2013 | Details |
| A45571 | 23840101 | Mediators Inflamm | Influence of gut microbiota on subclinical inflammation and insulin resistance. | 2013 | Details |
| A45621 | 23610585 | Hepat Mon | Probiotic as a novel treatment strategy against liver disease. | 2013 | Details |
| A45632 | 23536474 | Hepatology | Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. | 2013 | Details |
| A45658 | 23409094 | PLoS One | Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. | 2013 | Details |
| A45705 | 23177179 | Nutr Metab Cardiovasc Dis | Probiotics in the treatment of non alcoholic fatty liver disease: further evidence in obese children. | 2012 | Details |
| A45706 | 23175343 | Postepy Hig Med Dosw (Online) | [Role of sphingolipids in digestive system]. | 2012 | Details |
| A45716 | 23126101 | Nihon Rinsho | [Extraintestinal complications of inflammatory bowel disease]. | 2012 | Details |
| A45718 | 23112961 | Front Cell Infect Microbiol | Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. | 2012 | Details |
| A45745 | 22985643 | Gastrointest Endosc | Endoluminal bariatric therapy: beyond weight loss. | 2012 | Details |
| A45770 | 22848224 | Int J Microbiol | Microbial translocation in chronic liver diseases. | 2012 | Details |
| A45784 | 22763792 | Curr Gastroenterol Rep | Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? | 2012 | Details |
| A45794 | 22701308 | J Biomed Biotechnol | Think small: zebrafish as a model system of human pathology. | 2012 | Details |
| A45805 | 22648736 | J Cachexia Sarcopenia Muscle | Consilience in sarcopenia of cirrhosis. | 2012 | Details |
| A45878 | 22230269 | Am Fam Physician | Cirrhosis: diagnosis, management, and prevention. | 2011 | Details |
| A45891 | 22181567 | Pediatr Int | Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation. | 2011 | Details |
| A45896 | 22157220 | J Clin Gastroenterol | Gastrointestinal and hepatic manifestations of Sjogren syndrome. | 2012 | Details |
| A45900 | 22152377 | Zhonghua Gan Zang Bing Za Zhi | [The pathophysiological role of gut in non-alcoholic fatty liver disease]. | 2011 | Details |
| A45912 | 22122483 | Curr Pharm Biotechnol | Intestinal MicrobiOMICS to define health and disease in human and mice. | 2012 | Details |
| A45919 | 22089363 | South Med J | Physical activity benefits and risks on the gastrointestinal system. | 2011 | Details |
| A45920 | 22087157 | Hepat Mon | Liver complications in celiac disease. | 2011 | Details |
| A45931 | 21994857 | Int J Hepatol | Hepatobiliary disorders in celiac disease: an update. | 2010 | Details |
| A45954 | 21885692 | Cleve Clin J Med | Hepatic encephalopathy: suspect it early in patients with cirrhosis. | 2011 | Details |
| A45965 | 21807932 | JPEN J Parenter Enteral Nutr | Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. | 2011 | Details |
| A45993 | 21703167 | J Hepatol | Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease. | 2011 | Details |
| A46066 | 21314876 | Int J Clin Pract | Adiponectin in non-alcoholic fatty liver disease treatment: therapeutic perspectives and unresolved dilemmas. | 2011 | Details |
| A46132 | 20846208 | Int J Clin Pract | Non-alcoholic fatty liver disease and pharmacological options. | 2010 | Details |
| A46144 | 20731092 | Voen Med Zh | [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. | 2010 | Details |
| A46198 | 20415823 | Dermatol Ther | Psoriasis, the liver, and the gastrointestinal tract. | 2010 | Details |
| A46203 | 20385430 | J Hepatol | Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? | 2010 | Details |
| A46277 | 19826976 | Semin Liver Dis | Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use. | 2009 | Details |
| A46348 | 19387919 | Semin Liver Dis | Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. | 2009 | Details |
| A46367 | 19271298 | J Pediatr Gastroenterol Nutr | Intestinal microbiota during infancy and its implications for obesity. | 2009 | Details |
| A46375 | 19210115 | Expert Rev Gastroenterol Hepatol | Diagnosis of small intestinal bacterial overgrowth: the challenges persist! | 2009 | Details |
| A46391 | 19093209 | Dig Dis Sci | Steatocholecystitis and fatty gallbladder disease. | 2008 | Details |
| A46444 | 18619079 | Am Fam Physician | Gastrointestinal complications of diabetes. | 2008 | Details |
| A46451 | 18542037 | J Clin Gastroenterol | Probiotics and liver disease. | 2008 | Details |
| A46472 | 18403923 | Curr Opin Clin Nutr Metab Care | The impact of bariatric surgery on nonalcoholic fatty liver disease. | 2008 | Details |
| A46494 | 18271277 | Wei Sheng Wu Xue Bao | [The intestinal microbiota and obesity of the host]. | 2007 | Details |
| A46523 | 17970873 | J Dig Dis | Changing trends in gastrointestinal disease in the Asia-Pacific region. | 2007 | Details |
| A46583 | 17461479 | World J Gastroenterol | Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. | 2007 | Details |
| A46639 | 16970019 | Am Fam Physician | Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. | 2006 | Details |
| A46735 | 16085912 | Clin Diagn Lab Immunol | Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. | 2005 | Details |
| A46773 | 15703606 | Curr Opin Gastroenterol | Innate immunity in the liver. | 2003 | Details |
| A46813 | 15017614 | Clin Gastroenterol Hepatol | Liver abnormalities in celiac disease. | 2004 | Details |
| A46903 | 35053298 | Cells | NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease. | 2022 | Details |
| A46914 | 34513903 | Front Nutr | The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. | 2021 | Details |
| A46922 | 34198609 | Cells | Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. | 2021 | Details |
| A46925 | 34068838 | Nutrients | Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease. | 2021 | Details |
| A46931 | 33816353 | Front Cell Infect Microbiol | Streptococcus, the Predominant Bacterium to Predict the Severity of Liver Injury in Alcoholic Liver Disease. | 2021 | Details |
| A46936 | 33598648 | JHEP Rep | Gut dysbiosis as a driver in alcohol-induced liver injury. | 2020 | Details |
| A46940 | 33443222 | Proc Natl Acad Sci U S A | Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22. | 2020 | Details |
| A46951 | 32879433 | Commun Biol | Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice. | 2020 | Details |
| A46956 | 32583604 | Mol Nutr Food Res | Microbial Products and Metabolites Contributing to Alcohol-Related Liver Disease. | 2020 | Details |
| A46958 | 32418220 | Hepatology | Inhibition of Sphingosine-1-Phosphate-Induced Th17 Cells Ameliorates Alcohol-Associated Steatohepatitis in Mice. | 2021 | Details |
| A46959 | 32404932 | Lab Invest | Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. | 2020 | Details |
| A46960 | 32306456 | Liver Int | Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease. | 2020 | Details |
| A46969 | 31955762 | Food Res Int | Alteration of gut microbiota composition by short-term low-dose alcohol intake is restored by fermented rice liquor in mice. | 2019 | Details |
| A46976 | 31586017 | J Lipid Res | Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury. | 2019 | Details |
| A46986 | 31241423 | J Am Coll Nutr | Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish. | 2019 | Details |
| A46987 | 31188604 | J Proteome Res | Profiling of Polar Metabolites in Mouse Feces Using Four Analytical Platforms to Study the Effects Of Cathelicidin-Related Antimicrobial Peptide in Alcoholic Liver Disease. | 2019 | Details |
| A46996 | 30857422 | FASEB J | Solid-state fermented Chinese alcoholic beverage (baijiu) and ethanol resulted in distinct metabolic and microbiome responses. | 2019 | Details |
| A46997 | 30803859 | Dig Liver Dis | FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. | 2019 | Details |
| A47002 | 30660600 | Alcohol | Usefulness of adult medaka fish as a model for the evaluation of alcoholic fatty liver. | 2019 | Details |
| A47004 | 30643227 | Nat Rev Gastroenterol Hepatol | Alcohol, liver disease and the gut microbiota. | 2019 | Details |
| A47012 | 30105955 | Exp Biol Med (Maywood) | Mulberry and dandelion water extracts prevent alcohol-induced steatosis with alleviating gut microbiome dysbiosis. | 2018 | Details |
| A47013 | 30071471 | Redox Biol | Pomegranate prevents binge alcohol-induced gut leakiness and hepatic inflammation by suppressing oxidative and nitrative stress. | 2018 | Details |
| A47042 | 28424943 | Dig Dis Sci | Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice. | 2017 | Details |
| A47044 | 28228158 | Lipids Health Dis | Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. | 2017 | Details |
| A47071 | 26867181 | Cell Host Microbe | Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. | 2016 | Details |
| A47076 | 26751488 | Biomolecules | Alcoholic Liver Disease: Update on the Role of Dietary Fat. | 2016 | Details |
| A47078 | 26626356 | J Microbiol | Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. | 2015 | Details |
| A47079 | 26617183 | Toxicol Lett | Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding. | 2015 | Details |
| A47083 | 26556636 | Alcohol Clin Exp Res | Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. | 2015 | Details |
| A47108 | 25872593 | Alcohol Clin Exp Res | Alcoholic liver disease: the gut microbiome and liver cross talk. | 2015 | Details |
| A47118 | 25622859 | J Nutr Biochem | Enhanced AMPK phosphorylation contributes to the beneficial effects of Lactobacillus rhamnosus GG supernatant on chronic-alcohol-induced fatty liver disease. | 2014 | Details |
| A47123 | 25559494 | Alcohol | The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomized controlled trial. | 2014 | Details |
| A47127 | 25462064 | Redox Biol | Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness. | 2014 | Details |
| A47173 | 24214181 | Hepatology | Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice. | 2014 | Details |
| A47176 | 24155903 | PLoS One | Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors. | 2013 | Details |
| A47182 | 23969550 | Alcohol Alcohol | Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice. | 2013 | Details |
| A47186 | 23815146 | Nutr Rev | Ethanol metabolism and its effects on the intestinal epithelial barrier. | 2013 | Details |
| A47195 | 23408358 | Hepatology | Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. | 2013 | Details |
| A47197 | 23277536 | J Pharmacol Exp Ther | Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. | 2012 | Details |
| A47199 | 23206305 | Zhonghua Gan Zang Bing Za Zhi | [Changes in the intestinal microenvironment during development of alcoholic fatty liver disease and related effects of probiotic therapy]. | 2012 | Details |
| A47273 | 19645728 | Alcohol Clin Exp Res | Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. | 2009 | Details |
| A47310 | 17681030 | Alcohol Clin Exp Res | Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion--absence of subset-specific glucocorticoid-induced immune cell loss. | 2007 | Details |
| A47323 | 17058832 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Relationship between alcoholic liver injury and endotoxin leakage from gut and intervention effect of jianpi liqi huoxue decoction]. | 2006 | Details |
| A47326 | 16958678 | J Gastroenterol Hepatol | Unfolding new mechanisms of alcoholic liver disease in the endoplasmic reticulum. | 2006 | Details |
| A47337 | 16115302 | J Intern Med | Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. | 2005 | Details |
| A47352 | 14647036 | J Lab Clin Med | Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice. | 2003 | Details |
| A47389 | 9622397 | Alcohol Clin Exp Res | Alcohol-related problems in Taiwan with particular emphasis on alcoholic liver diseases. | 1998 | Details |
| A47527 | 3080046 | Br Med J (Clin Res Ed) | Ultrasound scanning in the detection of hepatic fibrosis and steatosis. | 1986 | Details |